PH01000024G1630's details annotation
1.Annotation
ICBR annotation: OsQSOXL1 quiescin-sulfhydryl oxidase-like OsQSOXL1, expressed
Blast result AT2G01270 : 6.00E-134
Blast annotation: quiescin-sulfhydryl oxidase 2
2.Location
Scaffold: PH01000024
Strand: +
| Region | Start | End |
| gene | 1133904 | 1143152 |
| mRNA | 1133904 | 1143152 |
| exon | 1133904 | 1134767 |
| exon | 1138787 | 1138811 |
| exon | 1139442 | 1139534 |
| exon | 1139854 | 1140101 |
| exon | 1140276 | 1140348 |
| exon | 1140465 | 1140533 |
| exon | 1140616 | 1140689 |
| exon | 1140768 | 1140921 |
| exon | 1141445 | 1141485 |
| exon | 1141902 | 1143152 |
| CDS | 1134550 | 1134767 |
| CDS | 1138787 | 1138811 |
| CDS | 1139442 | 1139534 |
| CDS | 1139854 | 1140101 |
| CDS | 1140276 | 1140348 |
| CDS | 1140465 | 1140533 |
| CDS | 1140616 | 1140689 |
| CDS | 1140768 | 1140921 |
| CDS | 1141445 | 1141485 |
| CDS | 1141902 | 1142385 |
3.Network
| Co-expression Network Category | Global Network | Conditional Network | |
| Co-expression Positive |
Top300 PCC genelist MR network genelist |
Top300 PCC genelist MR network genelist |
|
| Co-expression Negative |
Top300 PCC genelist MR network genelist |
Top300 PCC genelist MR network genelist |
|
| Predict protein-portein interaction | null | ||
| miRNA-targets relationship | null | ||
4.Functional module
| Method | Module ID | Function Annotation |
| coexpression network | null | null |
5.Cis-elements
Details in 3kb promoter region
6.Expression profilings
7.Gene family
| Category | Family |
| null | null |
8.Protein domain
| Pfam Accession | Pfam Annotation | Alignment Start | Alignment Start |
| PF00085.19 | Thioredoxin | 47 | 139 |
| PF04777.12 | Evr1_Alr | 337 | 377 |
9.KEGG Pathway
| Pathway | KEGG Ortholog | Pathway ID | KO |
| null | null | null | null |
10.Gene Ontology
| GO Accession | GO Annotation |
| GO:0016972 | thiol oxidase activity |
| GO:0045454 | cell redox homeostasis |
| GO:0055114 | oxidation-reduction process |
Maintained by Xuelian Ma - Zhen Su's Lab - China Agricultural University
© 2017 All Rights Reserved.
© 2017 All Rights Reserved.